Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/41083
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | DEWACHTER, Ilse | |
dc.contributor.advisor | BEEKEN, Jolien | |
dc.contributor.author | Luykx, Anaïs | |
dc.date.accessioned | 2023-09-21T07:48:58Z | - |
dc.date.available | 2023-09-21T07:48:58Z | - |
dc.date.issued | 2023 | |
dc.identifier.uri | http://hdl.handle.net/1942/41083 | - |
dc.format.mimetype | Application/pdf | |
dc.language | en | |
dc.publisher | tUL | |
dc.title | Validation of preclinical cellular models to screen the effectiveness of drugs directed to slow down Alzheimer’s and Parkinson’s disease progression | |
dc.type | Theses and Dissertations | |
local.bibliographicCitation.jcat | T2 | |
dc.description.notes | Master of Biomedical Sciences-Molecular Mechanisms in Health and Disease | |
local.type.specified | Master thesis | |
item.fulltext | With Fulltext | - |
item.accessRights | Open Access | - |
item.fullcitation | Luykx, Anaïs (2023) Validation of preclinical cellular models to screen the effectiveness of drugs directed to slow down Alzheimer’s and Parkinson’s disease progression. | - |
item.contributor | Luykx, Anaïs | - |
Appears in Collections: | Master theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
11937820-d149-4ebc-b650-1f6e13f1a1dc.pdf | 1.9 MB | Adobe PDF | View/Open |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.